Categories
Connect with us on LinkedIn
Implications of Assessing Overall Survival in Oncology Studies
The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in...
Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research
Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This...
Oncology factsheet
Download our oncology factsheet to view an overview of our services.
What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more
Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,...
Measuring the true patient experience in Cancer Trials with eCOA / ePRO
Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer...
